Norway's Borregaard Q2 EBITDA beats on higher deliveries at Fine Chemicals unit

BORREGAARD ASA

16/07/2026 06:10

Overview
Norway specialty chemicals producer's Q2 EBITDA beat analyst expectations
Q2 profit before tax and EPS turned negative due to Alginor impairment and site costs
Company to implement cost programme targeting NOK 150 mln annual savings by 2028

Outlook
Borregaard is implementing a cost improvement programme targeting annual savings of NOK 150 mln by 2028
Company says Middle East conflict continues to impact energy, logistics and chemical costs

Result Drivers
BIOMATERIALS PRODUCTION - Record production in BioMaterials contributed positively to results, though partly offset by lower sales prices and weaker product mix
BIOSOLUTIONS COST PRESSURE - Higher energy and related costs, negative currency effects, and less favourable product mix outweighed higher sales volume in BioSolutions
FINE CHEMICALS DELIVERIES - Higher deliveries and a favourable product mix improved Fine Chemicals results

Company press release: ID:nGNE2jN5xw

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 EBITDA
Beat
NOK 515 mln
NOK 434.18 mln (5 Analysts)

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Borregaard ASA is NOK167.50, about 10.6% above its July 15 closing price of NOK151.40
The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 17 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)